首站-论文投稿智能助手
典型文献
Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway
文献摘要:
Primary hepatic carcinoma is a common malignant tumor.The classic molecular targeted drug sorafenib is costly and is only effective for some patients.Therefore,it is of great clinical significance to search for new molecular targeted drugs.Eupalinolide B(EB)from Eupatorium lindleyanum DC.is used to treat chronic tracheitis in clinical practice.However,the role of EB in hepatic carcinoma is unknown.In this study,we first measure the effect of EB on tumor growth in a xenograft model and PDX model.The cell proliferation and migration are also detected in human hepatocarcinoma cell lines(SMMC-7721 and HCCLM3).Then,we investigate cell cycle,cell apoptosis,cell necrosis,cell autophagy,and ferroptosis by flow cytometry,western blot analysis and electron microscopy.The results demonstrate that EB exerts anti-proliferative activity in hepatic carcinoma by blocking cell cycle arrest at S phase and inducing ferroptosis mediated by endoplasmic reticulum(ER)stress,as well as HO-1 activation.When HO-1 is inhibited,EB-induced cell death and ER protein expression are rescued.The migration-related mechanism consists of activation of the ROS-ER-JNK signaling pathway and is not connected to ferroptosis.In summary,we first discover that EB inhibits cell proliferation and migration in hepatic carcinoma,and thus EB is a promising anti-tumor compound that can be used for hepatic carcinoma.
文献关键词:
作者姓名:
Yonghui Zhang;Haoyang Zhang;Jinage Mu;Meiyue Han;Zhihao Cao;Feng Dong;Tingting Wang;Lian Pan;Wujing Luo;Jiaxin Li;Huan Liu;Lishan Jin;Wenxuan Ding;Yong Wei;Xuesong Deng;Dan Liu;Xiuzhen He;Yi Pang;Xiao Mu;Zhongjun Wu;Dilong Chen
作者机构:
The First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China;The People's Hospital Affiliated to Chongqing Three Gorges Medical College,Chongqing 404100,China;Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area,Chongqing 404120,China;Chongqing Engineering Research Center of Antitumor Natural Drugs,Chongqing 404120,China;Key Laboratory of Intelligent Information Processing and Control,College of Electronic and Information Engineering,Chongqing Three Gorges University,Chongqing 404110,China
引用格式:
[1]Yonghui Zhang;Haoyang Zhang;Jinage Mu;Meiyue Han;Zhihao Cao;Feng Dong;Tingting Wang;Lian Pan;Wujing Luo;Jiaxin Li;Huan Liu;Lishan Jin;Wenxuan Ding;Yong Wei;Xuesong Deng;Dan Liu;Xiuzhen He;Yi Pang;Xiao Mu;Zhongjun Wu;Dilong Chen-.Eupalinolide B inhibits hepatic carcinoma by inducing ferroptosis and ROS-ER-JNK pathway)[J].生物化学与生物物理学报(英文版),2022(07):974-986
A类:
Eupalinolide,lindleyanum,tracheitis
B类:
inhibits,hepatic,by,inducing,ferroptosis,ROS,ER,JNK,pathway,Primary,common,malignant,tumor,classic,molecular,targeted,sorafenib,costly,only,effective,some,patients,Therefore,great,clinical,significance,search,new,drugs,EB,from,Eupatorium,DC,used,treat,chronic,practice,However,role,unknown,In,this,study,first,measure,growth,xenograft,model,PDX,cell,proliferation,migration,are,also,detected,human,hepatocarcinoma,lines,SMMC,HCCLM3,Then,investigate,cycle,apoptosis,necrosis,autophagy,flow,cytometry,western,blot,analysis,electron,microscopy,results,demonstrate,that,exerts,anti,proliferative,activity,blocking,arrest,phase,mediated,endoplasmic,reticulum,stress,well,HO,activation,When,inhibited,induced,death,protein,expression,rescued,related,mechanism,consists,signaling,not,connected,summary,discover,thus,promising,compound,be
AB值:
0.540507
相似文献
SNORA23 inhibits HCC tumorigenesis by impairing the 2?-O-ribose methylation level of 28S rRNA
Zhiyong Liu;Yanan Pang;Yin Jia;Qin Qin;Rui Wang;Wei Li;Jie Jing;Haidong Liu;Shanrong Liu-Department of Laboratory Diagnostics,Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Department of Gastroenterology and Hepatology,Zhongshan Hospital,Fudan University,Shanghai 200032,China;Department of Gastroenterology,Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Shanghai Institute of Pancreatic Diseases,Shanghai 200433,China;Department of Chemistry and State Key Laboratory of Molecular Engineering of Polymers,Fudan University,Shanghai 200433 China;Department of General Surgery,Changzheng Hospital,Second Military Medical University,Shanghai 200433,China;Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin
Na Hui Kim;Minji Kwon;Jiwoo Jung;Hyo Byeong Chae;Jiwoo Lee;Yeo-Jun Yoon;In Seok Moon;Ho K.Lee;Wan Namkung;Konstantina M.Stankovic;Se A.Lee;Jong Dae Lee;Sin-Aye Park-Department of ICT Environmental Health System,Graduate School,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Biomedical Laboratory Science,College of Medical Sciences,Soonchunhyang University,Asan-si 31538,Republic of Korea;Department of Otorhinolaryngology,Yonsei University,College of Medicine,Seoul 03722,Republic of Korea;Colllege of Pharmacy and Yonsei Institute of Pharmaceutical Sciences,Yonsei University,Yeonsu-gu,Incheon 21983,Republic of Korea;Department of Otolaryngology-Head and Neck Surgery,Stanford University School of Medicine,Stanford,CA 94305,USA;Department of Otorhinolaryngology-Head and Neck Surgery,Soonchunhyang University Bucheon Hospital,Bucheon 14584,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。